Laserfiche WebLink
A number of other diseases have been investigated for possible association with ELF <br />magnetic field exposure. These include cancers in children and adults, depression, <br />suicide, reproductive dysfunction, developmental disorders, immunological <br />modifications and neurological disease. The scientific evidence supporting a linkage <br />between ELF magnetic fields and any of these diseases is much weaker than for <br />childhood leukemia and in some cases (for example, for cardiovascular disease or <br />breast cancer) the evidence is sufficient to give confidence that magnetic fields do <br />not cause the disease. (Id. at p. 12.) <br />Furthermore, in their "Summary and Recommendations for Further Study" WHO emphasized that: <br />The limit values in [ELF -MF] exposure guidelines [should not] be reduced to some <br />arbitrary level in the name of precaution. Such practice undermines the scientific <br />foundation on which the limits are based and is likely to be an expensive and not <br />necessarily effective way of providing protection. (Id. at p. 12). <br />Although WHO recognized epidemiological studies indicate an association on the range of three to <br />four mG, WHO did not recommend these levels as an exposure limit but instead provided: "The <br />best source of guidance for both exposure levels and the principles of scientific review are <br />international guidelines." Id. at pp. 12-13. The international guidelines referred to by WHO are the <br />International Commission on Non -Ionizing Radiation Protection ("ICNIRP") and the Institute of <br />Electrical and Electronic Engineers ("IEEE") exposure limit guidelines to protect against acute <br />effects. Id. at p. 12. The ICNIRP-1998 continuous general public exposure guideline is 833 mG and <br />the IEEE continuous general public exposure guideline in 9,040 mG. In addition, WHO <br />determined that "the evidence for a casual relationship [between ELF -MF and childhood leukemia] <br />is limited, therefore exposure limits based on epidemiological evidence is not recommended, but <br />some precautionary measures are warranted." Id. at 355-56. <br />WHO concluded that: <br />given both the weakness of the evidence for a link between exposure to ELF magnetic <br />fields and childhood leukemia, and the limited impact on public health if there is a <br />link, the benefits of exposure reduction on health are unclear. Thus, the costs of <br />precautionary measures should be very low... Provided that the health, social and <br />economic benefits of electric power are not compromised, implementing very low-cost <br />precautionary procedures to reduce exposure is reasonable and warranted. (Id at p. 13). <br />Wisconsin, Minnesota and California have all conducted literature reviews or research to examine <br />this issue. In 2002, Minnesota formed an Interagency Working Group ("Working Group") to <br />evaluate the body of research and develop policy recommendations to protect the public health <br />from any potential problems resulting from HVTL EMF effects. The Working Group consisted of <br />staff from various state agencies and published its findings in a White Paper on Electric and <br />Magnetic Field (EMF) Policy and Mitigation Options in September 2002, (Minnesota Department of <br />Health, 2002). The report summarized the findings of the Working Group as follows: <br />Research on the health effects of EMF has been carried out since the 1970s. <br />Epidemiological studies have mixed results — some have shown no statistically <br />significant association between exposure to EMF and health effects, some have <br />shown a weak association. More recently, laboratory studies have failed to show such <br />Orono Project June 7, 2011 <br />MPUC Docket No. E002/TL-11-223 34 <br />